Rockwell Medical (RMTI) EPS (Weighted Average and Diluted) (2010 - 2026)
Rockwell Medical (RMTI) reported EPS (Weighted Average and Diluted) of -$0.04 for Q1 2026, little changed on a YoY basis from -$0.04 in Q1 2025, and down 300.0% quarter-over-quarter from -$0.01 in Q4 2025.
Rockwell Medical (RMTI) EPS (Weighted Average and Diluted) (2010 - 2026) Analysis & Trends
Rockwell Medical has reported EPS (Weighted Average and Diluted) for 16 years, with the latest figure at -$0.04 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.04; the trailing twelve-month figure through Mar 2026 stood at -$0.15 (down 400.0% YoY), and the FY2025 full-year result was -$0.15, down 400.0% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.04, down from -$0.01 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.04 in Q3 2024, with the low at -$0.84 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.13 across 5 years, with a median of -$0.05 in 2025.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) surged 157.14% — and 2025, when it plunged 600.0%.
- Rockwell Medical's EPS (Weighted Average and Diluted) stood at -$0.05 in 2022, then rose by 0.0% to -$0.05 in 2023, then gained by 20.0% to -$0.04 in 2024, then soared by 75.0% to -$0.01 in 2025, then plunged by 300.0% to -$0.04 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.04 (Q1 2026), -$0.01 (Q4 2025), and -$0.05 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.05 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | -0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.10 |
| Dec 31, 2022 | -0.05 |
| Sep 30, 2022 | -0.23 |
| Jun 30, 2022 | -0.43 |
| Mar 31, 2022 | -0.84 |
| Dec 31, 2021 | -1.04 |
| Sep 30, 2021 | -0.89 |
| Jun 30, 2021 | -0.99 |